| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Accounting Fees | 6,000 | 0 | 0 | 6,000 |
| Name of Stock | End of Year Book Value | End of Year Fair Market Value |
|---|---|---|
| Calls / Options | 15,618 | 2,662 |
| IBM | 565,440 | 659,490 |
| Johnson & Johnson | 210,936 | 173,544 |
| Merck & Co | 173,352 | 159,168 |
| Margin Loan | ||
| ABBVIE | 134,965 | 177,700 |
| AMGEN | 288,335 | 260,640 |
| CVS | ||
| Goldman Sachs | 178,199 | 286,310 |
| Honeywell | 186,755 | 225,890 |
| Solventum Corp | 58,205 | 66,060 |
| Description | Revenue and Expenses per Books | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Bank Fees | 50 |
| Category | Amount | Net Investment Income | Adjusted Net Income | Disbursements for Charitable Purposes |
|---|---|---|---|---|
| Asset Management Fee | 50,149 | 50,149 | 0 | 0 |